Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2022International Journal of Pharmaceutical Quality AssuranceOpen Access

A Novel Stability Indicating Reversed Phase Ultra Performance Liquid Chromatography Method for Estimation of Asciminib its Bulk and Tablet Formulation

View Full Paper
Ask AI
Bookmark
Share

Authors

SGShivakumar . GubbiyappaGITAM UniversityVRVasanthi . Rangapuram

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gubbiyappa et al. (2022) studied this question.

synapsesocial.com/papers/6a937fed0d31bab2d3e1ba85https://doi.org/10.25258/ijpqa.13.4.23
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of forced degradation and stability indicating studies of drugs—A review2013 · 1,042 citations
  2. 2Asciminib: a new therapeutic option in chronic-phase CML with treatment failure2022 · 47 citations
  3. 3Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL12018 · 469 citations
  4. 4Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects2019 · 30 citations